This report provides nine recommendations to ensure Australia is ready to combat the rise of drug resistant infections.

Respiratory syncytial virus (RSV) is the leading cause of hospitalisation for Australian infants and children under 5 years, yet it does not receive the same attention as other common respiratory viruses, such as influenza and COVID-19. This publication analyses the burden of RSV among infants and children in Australia for patients and their families, the...

This white paper provides a high-level design for a national, nurses-to-nurses model for skin cancer care, and explores the potential benefits of such a model for patients, nurses and the broader healthcare system.

This white paper analyses the current state of chimeric antigen receptor (CAR) T-cell therapy in Australia, expected opportunities and our healthcare system’s preparedness for delivering CAR T-cell therapy at scale.